Human myiasis is an infestation of living tissue by dipteran (fly) larvae. It ranges from superficial, self-limited lesions to destructive, invasive disease with substantial morbidity. The condition is often summarized as “flesh-eating,” but the underlying pathobiology varies by species, host factors, and the depth of larval penetration. Clinically, myiasis can present as localized boils, pruritic nodules, ulcerated lesions with serosanguinous discharge, and sometimes a palpable or visible larva or “tumor-like” mass. In the most severe forms, larvae may invade deeper tissues, leading to necrosis, secondary bacterial infection, and extensive tissue damage.
Mechanisms of disease involve larval attachment and feeding behavior. Many species create an anchoring site in the skin while secreting proteolytic enzymes that facilitate tissue breakdown. Others may use host fluids as a nutrient source, producing localized inflammation and tissue destruction indirectly through enzymatic degradation and immune-mediated injury. The host’s immune response—including neutrophil and macrophage recruitment—contributes to swelling, erythema, and ulceration. Comorbidities such as diabetes mellitus, immunosuppression, poor wound care, and impaired mobility increase susceptibility by reducing local defenses and delaying healing, thereby creating a favorable microenvironment for egg deposition and larval survival.
Risk factors commonly include exposure to endemic geographic regions, contact with animals harboring larvae, and compromised skin integrity. Chronic wounds, ulcers, traumatic injuries, and neglected tinea or dermatitis can act as portals of entry. In community settings, sanitation and access to basic wound management are relevant determinants. Clinical suspicion should be heightened in any patient with a nonhealing wound accompanied by pain, an expanding ulcer, discharge with possible larvae, or a sensation of movement.
Classification is important because management differs. Cutaneous myiasis involves the skin. Furuncular myiasis presents as a boil-like lesion with a central punctum and intermittent serous or bloody drainage; larvae may be hidden within the lesion. Wound myiasis is associated with open ulcers or traumatic wounds. Traumatic myiasis occurs after wounds or injuries. Less commonly, myiasis can be nasal, aural, ocular, or even systemic (e.g., invasive forms with multiple organs). Systemic involvement typically indicates widespread larval migration or heavy infestation, often in high-risk hosts.
Diagnosis is primarily clinical, supported by visualization and confirmation of larvae. A careful examination can reveal an opening, exudate, or the larva itself. For furuncular lesions, imaging is not always required, but ultrasound or radiographs can help define depth when deep invasion is suspected. Laboratory studies may show inflammation and secondary infection (elevated leukocytes, C-reactive protein) rather than specific diagnostic patterns. Definitive identification may be done by entomological examination of the extracted larvae, which can inform prognosis and public-health interventions.
Treatment is evidence-based and centers on removal and infection control. First-line management typically includes occlusive or suffocating measures to reduce larval oxygenation, followed by careful extraction. Occlusion can be achieved with topical agents that limit air flow, though the exact choice should be clinician-guided to minimize skin maceration or burn risk. After removal, the wound should be irrigated with sterile saline, debrided if necessary, and dressed appropriately. Because secondary bacterial infection is common, topical or systemic antibiotics are used based on clinical assessment, culture results where feasible, and severity of surrounding cellulitis.
Surgical intervention may be required when larvae extend into deeper tissues, when there is significant necrosis, or when complete extraction cannot be achieved safely at the bedside. Pain control and tetanus prophylaxis should follow standard wound management protocols. Prevention is a public-health and bedside strategy: maintain hygiene, protect skin with coverage and repellents when exposed, promptly clean and treat wounds, and ensure chronic ulcer care. In endemic settings, early evaluation of any nonhealing lesion and education about wound hygiene can substantially reduce incidence.
Complications include local tissue destruction, scarring, recurrent infection, and, rarely, disseminated disease. For patients with diabetes or immunosuppression, delayed diagnosis increases risk of invasive spread and poor healing. Therefore, clinicians should adopt a structured approach: assess host risk factors, evaluate lesion depth and infection, remove larvae safely, treat infection, and arrange follow-up to ensure complete resolution.
Source: @RdclslyGudLookN
Curtis Thornton Jr: We can all do our part in the war against the flying flesh eating monsters. Use bait that smells like poo. Maybe someone will make themselves a handsome fortune selling aesthetic designs. No one is too poor to participate.. #breaking
— @RdclslyGudLookN May 1, 2026
SHOP AMAZON BEST SELLERS, CLICK TO BUY FROM AMAZON.
SHOP AMAZON BEST SELLERS, CLICK TO BUY FROM AMAZON.
